• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,360.01 13.84
( 0.02%)
Global Indices
Nasdaq
50,746.98 -581.81
(-1.13%)
Dow Jones
7,576.82 -53.96
(-0.71%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,340.87 -32.64
(-0.31%)
Forex
USD-INR
95.24 0.16
(0.17%)
EUR-INR
110.83 0.16
(0.15%)
GBP-INR
128.25 0.32
(0.25%)
JPY-INR
0.60 0.00
(0.02%)

EQUITY - MARKET SCREENER

Chartered Capital & Investment Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
511696
INE953B01010
568.4385382
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
29.41
79.67
EPS(TTM)
Face Value()
Div & Yield %
9
10
0
 

Aarti Drugs standalone net profit declines 26.87% in the March 2026 quarter
May 16,2026
Net profit of Aarti Drugs declined 26.87% to Rs 44.96 crore in the quarter ended March 2026 as against Rs 61.48 crore during the previous quarter ended March 2025. Sales rose 1.40% to Rs 631.68 crore in the quarter ended March 2026 as against Rs 622.96 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.57% to Rs 169.22 crore in the year ended March 2026 as against Rs 157.31 crore during the previous year ended March 2025. Sales rose 3.99% to Rs 2260.39 crore in the year ended March 2026 as against Rs 2173.65 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales631.68622.96 1 2260.392173.65 4
OPM %12.5514.23 -11.5412.08 -
PBDT73.5282.88 -11 236.95246.54 -4
PBT58.5770.67 -17 181.31198.75 -9
NP44.9661.48 -27 169.22157.31 8